|
MY125533A
(en)
*
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
|
PT1392359E
(pt)
|
2001-05-11 |
2010-01-27 |
Ludwig Inst For Cancer Res Ltd |
Proteínas de ligação específica e suas utilizações
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
TW200307539A
(en)
*
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
|
GB0205176D0
(en)
*
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
|
TW200403058A
(en)
*
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
|
JP2006505571A
(ja)
*
|
2002-10-15 |
2006-02-16 |
リゲル ファーマシューテイカルズ、インコーポレイテッド |
置換されたインドール及びｈｃｖ阻害剤としてのその使用
|
|
US7208491B2
(en)
*
|
2003-02-07 |
2007-04-24 |
Hoffmann-La Roche Inc. |
N-monoacylated o-phenylenediamines
|
|
US7078419B2
(en)
|
2003-03-10 |
2006-07-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Cytokine inhibitors
|
|
WO2005032594A2
(en)
*
|
2003-10-03 |
2005-04-14 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Alkylators linked to polyamides as dna binding agents
|
|
EA200901236A1
(ru)
*
|
2004-03-16 |
2009-12-30 |
Темпл Юниверсити - Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн |
Замещённые фенокси- и фенилтиопроизводные для лечения пролиферативных нарушений
|
|
WO2006053274A2
(en)
*
|
2004-11-15 |
2006-05-18 |
Bristol-Myers Squibb Company |
2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
|
|
WO2006055462A1
(en)
|
2004-11-15 |
2006-05-26 |
Bristol-Myers Squibb Company |
2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
|
|
US7365061B2
(en)
*
|
2004-11-15 |
2008-04-29 |
Bristol-Myers Squibb Company |
2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
|
|
WO2006055435A1
(en)
*
|
2004-11-15 |
2006-05-26 |
Bristol-Myers Squibb Company |
2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
|
|
US8782706B2
(en)
|
2005-12-29 |
2014-07-15 |
United Video Properties |
Systems and methods for providing channel groups in an interactive media guidance application
|
|
SI2035369T1
(sl)
|
2006-07-05 |
2014-11-28 |
Fibrotech Therapeutics Pty Ltd |
Terapevtske spojine
|
|
GB0619325D0
(en)
*
|
2006-09-30 |
2006-11-08 |
Univ Strathclyde |
New compounds
|
|
AR063311A1
(es)
*
|
2006-10-18 |
2009-01-21 |
Novartis Ag |
Compuestos organicos
|
|
WO2008050140A2
(en)
*
|
2006-10-27 |
2008-05-02 |
Spirogen Limited |
Compounds for treatment of parasitic infection
|
|
CN101711284A
(zh)
|
2007-01-25 |
2010-05-19 |
达娜-法勃肿瘤研究所 |
抗egfr抗体在治疗egfr突变体介导的疾病中的用途
|
|
JP5618549B2
(ja)
|
2007-03-15 |
2014-11-05 |
ルードヴィッヒ インスティテュート フォー キャンサーリサーチ リミテッド |
Ｅｇｆｒ抗体及びｓｒｃ阻害剤を用いる治療方法及び関連製剤
|
|
US9901567B2
(en)
|
2007-08-01 |
2018-02-27 |
Syntarga B.V. |
Substituted CC-1065 analogs and their conjugates
|
|
EP2188311B1
(en)
|
2007-08-14 |
2016-10-05 |
Ludwig Institute for Cancer Research Ltd. |
Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof
|
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
JP5677970B2
(ja)
|
2008-11-03 |
2015-02-25 |
シンタルガ・ビーブイ |
新規ｃｃ−１０６５類似体およびその複合体
|
|
US20110076232A1
(en)
*
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
|
EP2947073B1
(en)
*
|
2009-10-22 |
2019-04-03 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
|
US8697688B2
(en)
|
2010-04-15 |
2014-04-15 |
Seattle Genetics Inc. |
Pyrrolobenzodiazepines used to treat proliferative diseases
|
|
MX2012011900A
(es)
|
2010-04-15 |
2013-03-21 |
Seattle Genetics Inc |
Conjugados de pirrolobenzodiazepina diana.
|
|
NO3056203T3
(OSRAM)
|
2010-04-21 |
2018-05-12 |
|
|
|
BR112013031819B1
(pt)
|
2011-06-10 |
2022-05-03 |
Mersana Therapeutics, Inc |
Suporte polimérico, composição farmacêutica, composto, e, uso do suporte
|
|
EP2751120B1
(en)
|
2011-09-20 |
2018-08-22 |
MedImmune Limited |
Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
|
|
US9387259B2
(en)
|
2011-10-14 |
2016-07-12 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
CN103998450B
(zh)
|
2011-10-14 |
2017-03-08 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓
|
|
CN110183470A
(zh)
|
2011-10-14 |
2019-08-30 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓
|
|
CN102827061A
(zh)
*
|
2012-09-19 |
2012-12-19 |
兰州大学 |
5,6,7-三甲氧基吲哚类衍生物、制备方法及用途
|
|
WO2014057120A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
ES2680153T3
(es)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
|
|
EP2906249B1
(en)
|
2012-10-12 |
2018-06-27 |
MedImmune Limited |
Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
|
|
PL2906251T3
(pl)
|
2012-10-12 |
2018-02-28 |
Adc Therapeutics Sa |
Koniugaty pirolobenzodiazepina-przeciwciało anty-CD22
|
|
DK2906253T3
(en)
|
2012-10-12 |
2018-10-22 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine anti-PSMA antibody conjugates
|
|
DK2839860T3
(da)
|
2012-10-12 |
2019-06-17 |
Medimmune Ltd |
Pyrrolobenzodiazepiner og konjugater deraf
|
|
CN110256469B
(zh)
|
2012-10-12 |
2022-05-17 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓及其结合物
|
|
MX364329B
(es)
|
2012-10-12 |
2019-04-23 |
Medimmune Ltd |
Conjugados del anticuerpo pirrolobenzodiazepina.
|
|
WO2014057119A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
JP6334553B2
(ja)
|
2012-12-10 |
2018-05-30 |
メルサナ セラピューティクス，インコーポレイティド |
タンパク質−高分子−薬剤コンジュゲート
|
|
US9872918B2
(en)
|
2012-12-12 |
2018-01-23 |
Mersana Therapeutics, Inc. |
Hydroxyl-polymer-drug-protein conjugates
|
|
EA031585B1
(ru)
|
2012-12-21 |
2019-01-31 |
Медимьюн Лимитед |
Пирролобензодиазепины и их конъюгаты
|
|
CN105246894A
(zh)
|
2012-12-21 |
2016-01-13 |
斯皮罗根有限公司 |
用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
|
|
CN105142674B
(zh)
|
2013-03-13 |
2018-11-13 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓和其结合物
|
|
NZ710745A
(en)
|
2013-03-13 |
2019-03-29 |
Genentech Inc |
Pyrrolobenzodiazepines and conjugates thereof
|
|
KR102087850B1
(ko)
|
2013-10-11 |
2020-03-12 |
메르사나 테라퓨틱스, 인코포레이티드 |
단백질-고분자-약물 접합체
|
|
ES2754397T3
(es)
|
2013-10-11 |
2020-04-17 |
Asana Biosciences Llc |
Conjugados de proteína-polímero-fármaco
|
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
|
US9950078B2
(en)
|
2013-10-11 |
2018-04-24 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
GB201317981D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
HUE029672T2
(en)
|
2014-01-10 |
2017-03-28 |
Synthon Biopharmaceuticals Bv |
Duokarmicin-ADCs for use in the treatment of endometrial cancer
|
|
MX373458B
(es)
|
2014-01-10 |
2020-05-11 |
Byondis Bv |
Metodo para purificar conjugados de anticuerpo-farmaco enlazados a cisteina.
|
|
ES2668984T3
(es)
|
2014-01-10 |
2018-05-23 |
Synthon Biopharmaceuticals B.V. |
CAF de duocarmicina para su uso en el tratamiento del cáncer de vejiga
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN107148285B
(zh)
|
2014-11-25 |
2022-01-04 |
Adc治疗股份有限公司 |
吡咯并苯并二氮杂䓬-抗体缀合物
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
DE102016105449A1
(de)
*
|
2015-10-29 |
2017-05-04 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts |
Bifunktionale Prodrugs
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
EP3474901B1
(en)
|
2016-06-27 |
2025-08-06 |
Tagworks Pharmaceuticals B.V. |
Cleavable tetrazine used in bio-orthogonal drug activation
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
|
AU2018215089C1
(en)
|
2017-02-03 |
2022-09-22 |
Certa Therapeutics Pty. Ltd. |
Anti-fibrotic compounds
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
BR112019016373B1
(pt)
|
2017-02-08 |
2022-01-25 |
Medimmune Limited |
Conjugado anticorpo-fármaco que se liga ao axl, composição e composição farmacêutica que compreende o mesmo e uso terapêutico do dito conjugado
|
|
ES2926144T3
(es)
|
2017-04-18 |
2022-10-24 |
Medimmune Ltd |
Conjugados de pirrolobenzodiazepina
|
|
JP7408396B2
(ja)
|
2017-04-20 |
2024-01-05 |
アーデーセー セラピューティクス ソシエテ アノニム |
併用療法
|
|
PL3638373T3
(pl)
|
2017-06-14 |
2025-04-14 |
Adc Therapeutics Sa |
Schematy dawkowania dla podawania ADC anty-CD19
|
|
TW201905037A
(zh)
|
2017-06-22 |
2019-02-01 |
美商梅爾莎納醫療公司 |
藥物攜帶聚合物支架及蛋白質聚合物藥物共軛物之製造方法
|
|
EP3668874B1
(en)
|
2017-08-18 |
2021-12-22 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
ES2975330T3
(es)
|
2018-05-04 |
2024-07-04 |
Tagworks Pharmaceuticals B V |
Compuestos que comprenden un enlazador para aumentar la estabilidad del trans-cicloocteno
|
|
WO2019212356A1
(en)
|
2018-05-04 |
2019-11-07 |
Tagworks Pharmaceuticals B .V. |
Tetrazines for high click conjugation yield in vivo and high click release yield
|
|
EP3873534A1
(en)
|
2018-10-29 |
2021-09-08 |
Mersana Therapeutics, Inc. |
Cysteine engineered antibody-drug conjugates with peptide-containing linkers
|
|
MX2021010477A
(es)
|
2019-03-15 |
2021-10-01 |
Medimmune Ltd |
Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer.
|
|
IL289094A
(en)
|
2019-06-17 |
2022-02-01 |
Tagworks Pharmaceuticals B V |
Tetrazines for increasing the speed and yield of the "click release" reaction
|
|
WO2020256546A1
(en)
|
2019-06-17 |
2020-12-24 |
Tagworks Pharmaceuticals B.V. |
Compounds for fast and efficient click release
|
|
WO2021040393A1
(ko)
*
|
2019-08-26 |
2021-03-04 |
국제약품 주식회사 |
인돌 카복사미드 유도체 및 그를 포함하는 약제학적 조성물
|
|
EP4399283A2
(en)
|
2021-09-06 |
2024-07-17 |
Veraxa Biotech GmbH |
Novel aminoacyl-trna synthetase variants for genetic code expansion in eukaryotes
|
|
EP4186529B1
(en)
|
2021-11-25 |
2025-07-09 |
Veraxa Biotech GmbH |
Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
|
|
JP2024543916A
(ja)
|
2021-11-25 |
2024-11-26 |
ヴェラクサ バイオテック ゲーエムベーハー |
遺伝暗号拡張を利用した部位特異的結合によって調製された改良された抗体ペイロード複合体（ａｐｃ）
|
|
CN118574641A
(zh)
|
2021-12-08 |
2024-08-30 |
欧洲分子生物学实验室 |
用于制备靶向偶联物的亲水性四嗪官能化的负载物
|
|
US20250114489A1
(en)
|
2022-02-15 |
2025-04-10 |
Tagworks Pharmaceuticals B.V. |
Masked il12 protein
|
|
CA3261603A1
(en)
|
2022-07-15 |
2024-01-18 |
Pheon Therapeutics Ltd |
ANTIBODY-DRUG CONJUGATES
|
|
AU2023358214A1
(en)
|
2022-10-12 |
2025-05-08 |
Tagworks Pharmaceuticals B.V. |
Strained bicyclononenes
|
|
WO2024153789A1
(en)
|
2023-01-20 |
2024-07-25 |
Basf Se |
Stabilized biopolymer composition, their manufacture and use
|
|
CN121100004A
(zh)
|
2023-03-10 |
2025-12-09 |
泰克沃尔科斯制药有限公司 |
具有改进的t-连接子的反式-环辛烯
|
|
WO2025021929A1
(en)
|
2023-07-27 |
2025-01-30 |
Veraxa Biotech Gmbh |
Hydrophilic trans-cyclooctene (hytco) compounds, constructs and conjugates containing the same
|
|
WO2025056807A1
(en)
|
2023-09-15 |
2025-03-20 |
Basf Se |
Stabilized biopolymer composition, their manufacture and use
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|
|
WO2025174248A1
(en)
|
2024-02-16 |
2025-08-21 |
Tagworks Pharmaceuticals B.V. |
Trans-cyclooctenes with "or gate" release
|